L&G PHARMA BREAKTHROUGH ETF |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.15 USD | +0.76% |
|
+0.88% | -13.95% |
| 2018 | ETFS Pharma Breakthrough GO UCITS ETF has Changed its Name to L&G Pharma Breakthrough UCITS ETF | CI |
Investment objective
The L&G Pharma Breakthrough UCITS ETF (the 'ETF') aims to track the performance of the Solactive Pharma Breakthrough Value Index (the 'Index').
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 327.3 USD | +1.83% | +3.27% | +48.83% | 2.55% | ||
| 278.1 SEK | +0.47% | -1.21% | +4.27% | 2.55% | ||
| 3,260 JPY | +0.15% | +0.93% | +5.50% | 2.50% | ||
| - RUB | - | - | - | 2.48% | ||
| - GBX | -.--% | - | - | 2.48% | ||
| - AUD | -.--% | - | - | 2.48% | ||
| - USD | -.--% | - | - | 2.48% | ||
| - AUD | -.--% | - | - | 2.48% | ||
| - EUR | -.--% | - | - | 2.48% | ||
| - EUR | -.--% | - | - | 2.48% | ||
| - NOK | -.--% | - | - | 2.48% | ||
| 0.3938 CAD | -17.11% | - | - | 2.48% | ||
| 0.214 EUR | -.--% | - | - | 2.48% | ||
| 15.34 CAD | -0.78% | - | - | 2.48% | ||
| 21.1 CAD | -0.24% | - | - | 2.48% | ||
| 180 DKK | +2.08% | -2.86% | +1.38% | 2.41% | ||
| 221.6 USD | -3.69% | -2.85% | -14.37% | 2.40% | ||
| 6,550 JPY | -5.86% | -0.95% | -7.12% | 2.38% | ||
| 6,013 JPY | +0.43% | +2.31% | +55.29% | 2.37% | ||
| 1,781 DKK | -1.55% | +1.05% | -17.31% | 2.37% | ||
More news
In partnership with
Description
| IE00BF0H7608 | |
|---|---|
| Total Expense Ratio | 0.49% |
| Asset Class | Actions |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Solactive Pharma Breakthrough Value NTR Index - USD |
Features and characteristics
| Dividend Policy | Capitalisation |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Replication Model | |
| Date of creation |
2018-01-22
|
| Geographical Focus |
AuM evolution ( 2024-05-30 )
| AuM (EUR) | 17 M€ |
|---|---|
| AuM 1M | 17 M€ |
| AuM 3 months | 21 M€ |
| AuM 6 months | 28 M€ |
| AuM 12 months | 56 M€ |
- Stock Market
- ETF
- BIOT ETF
